Asthma drug cost- Big issue

THIRUVANANTHAPURAM

The Kerala State Human Rights Commission on Saturday ordered to look into the possible fcators for  increase in the price of medicine for chronic and acute asthma patients. Deadline of March 10 is given to the Health Secretary and Drugs Controller. The medicines are produced by a private company in Mumbai. The price of such medicines on the list of controlled drugs is highly regulated. Their prices are reviewed only once in 10 years. The drug which cost just Rs.4.70 is now Rs.42. Complaint filed by activist Thampi Surendran is acted upon by forum.

  • Related Posts

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

    Ludhiana police seize 56 kg ganja; courier warehouse under scanner

    The recovery has raised serious concerns over alleged lapses in parcel screening and monitoring within the logistics chain. The special cell of Ludhiana police has seized more than two quintals…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre gives custom cushion to supply strained Pharma, MedTech manufacturers

    Centre gives custom cushion to supply strained Pharma, MedTech manufacturers

    Delhi man arrested for running online racket selling counterfeit Ayurvedic products

    Delhi man arrested for running online racket selling counterfeit Ayurvedic products

    Customs Duty Exemption on Petrochemicals, AiMeD welcomes but Dil ‘Mange More’

    Customs Duty Exemption on Petrochemicals, AiMeD welcomes but Dil ‘Mange More’

    Sir Ganga Ram Hospital Launches Dialysis Center in Gurgaon for advanced care

    Sir Ganga Ram Hospital Launches Dialysis Center in Gurgaon for advanced care

    3-month relief: Final call for 10,000 pharmacists to renew registration

    3-month relief: Final call for 10,000 pharmacists to renew registration

    Marksans Pharma gets USFDA nod for generic Benzonatate capsules

    Marksans Pharma gets USFDA nod for generic Benzonatate capsules